Achilles Therapeutics PLC ADR (ACHL)
US$ 1.12980.87%
Price Chart
Key Statistics
Market Cap
$ 63.22M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
230.79K
52W High
$ 1.51
52W Low
$ 0.63
Dividend Yield
0.00%
Beta
1.25
Technicals
50-Day MA
1.3236
200-Day MA
1.0266
52 Week High
1.51
52 Week Low
0.63
About ACHL
Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors. Its platform identifies mutations formed early in the development of cancer.
Employees
204
Headquarters
London, United Kingdom
CEO
Dr. Iraj Ali Ph.D.
Latest News
Air Cargo Handling & Logistics (ACHL) - caasint.com
2024-11-29 • Google News
ACHL makes impression in Austria - Pro Hockey News
2025-01-19 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg